drugset / Trial / NCT00002704

Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia

NCT00002704 ↗

Phase 2 Completed 156 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase II trial to study the effectiveness of radiation therapy following chemotherapy in treating children with CNS relapse from acute lymphoblastic leukemia. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with radiation therapy may kill more cancer cells.

Timeline

Start
1996-01
Primary completion
2004-06
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Cytarabine Small molecule — Intrathecal
Subject Thiotepa Other / unclassified — —
Background 2-MERCAPTOETHANESULFONIC ACID Small molecule — —
Background Cyclophosphamide Other / unclassified — —
Background Daunorubicin Small molecule — —
Background Dexamethasone Small molecule — —
Background Etoposide Small molecule — —
Background Hydrocortisone Other / unclassified — —
Background Leucovorin Small molecule — —
Background MERCAPTOPURINE ANHYDROUS Small molecule — —
Background Methotrexate Small molecule — —
Background Vincristine Small molecule — —
Background asparaginase Protein / enzyme biologic — —
Background filgrastim Protein / enzyme biologic — —

Indications